Financial Lp Hrt Buys 137,541 Shares of NewGenIvf Group (NASDAQ:NIVF) Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt acquired 137,541 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were purchased at an average price of $0.99 per share, with a total value of $136,165.59. Following the acquisition, the insider owned 111,885 shares of the company’s stock, valued at approximately $110,766.15. This trade represents a -536.10% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Tuesday, May 26th, Financial Lp Hrt acquired 27,993 shares of NewGenIvf Group stock. The stock was acquired at an average price of $0.92 per share, with a total value of $25,753.56.

NewGenIvf Group Price Performance

Shares of NIVF traded up $0.08 on Wednesday, hitting $0.86. The company’s stock had a trading volume of 491,241 shares, compared to its average volume of 1,415,830. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. The firm’s fifty day moving average price is $1.71 and its 200-day moving average price is $7.16. NewGenIvf Group Limited has a fifty-two week low of $0.72 and a fifty-two week high of $1,839.00.

NewGenIvf Group (NASDAQ:NIVF) last issued its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million during the quarter. On average, analysts predict that NewGenIvf Group Limited will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.